Investor Letters
Here you can read our investor letters that are released about four times a year.
Stay updated on our progress and milestones
Neola Medical is currently in clinical phase with Neola®, undergoing our first clinical study on preterm born babies in Sweden. As the company approaches commercial launch, the focus is on securing market authorization in the U.S., followed by Europe.